Annual EBITDA
-$574.23 K
+$534.80 K+48.22%
December 31, 2022
Summary
- As of February 10, 2025, WENAW annual EBITDA is -$574.23 thousand, with the most recent change of +$534.80 thousand (+48.22%) on December 31, 2022.
- During the last 3 years, WENAW annual EBITDA has risen by +$534.80 thousand (+48.22%).
Performance
WENAW EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$396.88 K
-$152.65 K-62.50%
June 30, 2024
Summary
- As of February 10, 2025, WENAW quarterly EBITDA is -$396.88 thousand, with the most recent change of -$152.65 thousand (-62.50%) on June 30, 2024.
- Over the past year, WENAW quarterly EBITDA has dropped by -$152.65 thousand (-62.50%).
Performance
WENAW Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$396.88 K
-$152.65 K-62.50%
June 30, 2024
Summary
- As of February 10, 2025, WENAW TTM EBITDA is -$396.88 thousand, with the most recent change of -$152.65 thousand (-62.50%) on June 30, 2024.
- Over the past year, WENAW TTM EBITDA has dropped by -$152.65 thousand (-62.50%).
Performance
WENAW TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
WENAW EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +48.2% | -62.5% | -62.5% |
3 y3 years | +48.2% | -62.5% | -62.5% |
5 y5 years | +48.2% | -62.5% | -62.5% |
WENAW EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +93.1% | +62.5% | at low | +62.5% | at low |
5 y | 5-year | at high | +93.1% | +62.5% | at low | +62.5% | at low |
alltime | all time | at high | +93.1% | +62.5% | at low | +62.5% | at low |
Anew Medical EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2024 | - | -$396.88 K(+62.5%) | -$396.88 K(+62.5%) |
Jun 2023 | - | -$244.23 K | -$244.23 K |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | -$574.23 K(-48.2%) | - | - |
Dec 2021 | -$1.11 M | - | - |
FAQ
- What is Anew Medical annual EBITDA?
- What is the all time high annual EBITDA for Anew Medical?
- What is Anew Medical annual EBITDA year-on-year change?
- What is Anew Medical quarterly EBITDA?
- What is the all time high quarterly EBITDA for Anew Medical?
- What is Anew Medical quarterly EBITDA year-on-year change?
- What is Anew Medical TTM EBITDA?
- What is the all time high TTM EBITDA for Anew Medical?
- What is Anew Medical TTM EBITDA year-on-year change?
What is Anew Medical annual EBITDA?
The current annual EBITDA of WENAW is -$574.23 K
What is the all time high annual EBITDA for Anew Medical?
Anew Medical all-time high annual EBITDA is -$574.23 K
What is Anew Medical annual EBITDA year-on-year change?
Over the past year, WENAW annual EBITDA has changed by +$534.80 K (+48.22%)
What is Anew Medical quarterly EBITDA?
The current quarterly EBITDA of WENAW is -$396.88 K
What is the all time high quarterly EBITDA for Anew Medical?
Anew Medical all-time high quarterly EBITDA is -$244.23 K
What is Anew Medical quarterly EBITDA year-on-year change?
Over the past year, WENAW quarterly EBITDA has changed by -$152.65 K (-62.50%)
What is Anew Medical TTM EBITDA?
The current TTM EBITDA of WENAW is -$396.88 K
What is the all time high TTM EBITDA for Anew Medical?
Anew Medical all-time high TTM EBITDA is -$244.23 K
What is Anew Medical TTM EBITDA year-on-year change?
Over the past year, WENAW TTM EBITDA has changed by -$152.65 K (-62.50%)